Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Rabbit Antithymocyte Globulin in Low and Intermediate-1 Risk Myelodysplastic Syndrome
2007-002532-28Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jul 2007
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of antithymocyte globulin in myelodysplastic syndrome (MDS), sponsored by Sanofi. Primary endpoint: Hematologic improvement rate. Started Jul 2007; status: terminated.
02
Drugs
antithymocyte globulin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2007-002532-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002532-28.